Medifast director Daniel R. Chard disposes of $226,048 in common shares

MED•2026-10-01

Medifast director Daniel R. Chard disclosed sales of 19,089 common shares on Sept. 28-29, 2026, for $226,048. The Dan and Allyson Family Irrevocable Trust held 130,609 shares after the transactions.

1. Share sales disclosed

Chard sold 19,089 common shares on Sept. 28-29, 2026, at weighted-average prices of $11.9788 and $11.73. The Dan and Allyson Family Irrevocable Trust held 130,609 shares following the transactions.

Sources

Medifast director Daniel R. Chard disposes of $226,048 in common shares

Sec

Medifast director Daniel R. Chard disposes of $226,048 in common shares

1. Share sales disclosed

Related News

Soybeans rise ahead of USDA monthly report

Streamex co-founder Morgan Lekstrom to transition to independent director

Digimarc files initial beneficial ownership statement for Ocho Investments LLC

Sources

Medifast director Daniel R. Chard disposes of $226,048 in common shares

U.S. FDA approves expanded Camzyos indication for adults and pediatric patients with symptomatic OHCM

Goldman Sachs Private Middle Market Credit II unit extends loan termination date to January 15, 2027